mRNA vaccines have gained widespread attention for their crucial role in fighting the COVID-19 pandemic. Yet, even before the pandemic, researchers at Memorial Sloan Kettering Cancer Center were investigating the potential of mRNA vaccine technology in the fight against cancer. Leading this innovative research is Dr. Vinod Balachandran, a physician-scientist associated with the David M. Rubenstein Center for Pancreatic Cancer Research, the Human Oncology and Pathogenesis Program, and the Parker Institute for Cancer Immunotherapy. Dr. Balachandran’s groundbreaking efforts have paved the way for…